The primary objective is to compare cementation during TKA with a new cementing device to finger packing (the current best cementing technique) regarding cement distribution and cement penetration of the proximal tibia.The secondary objective is to…
ID
Source
Brief title
Condition
- Joint disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameters are the penetration and distribution of the cement
into the bone of the proximal tibia, measured with CT.
Secondary outcome
The secondary parameter is the measured operation time.
Background summary
Aseptic loosening is a common problem in joint arthroplasty and one of the most
common indications for revision arthroplasty in total knee arthroplasty (TKA).
Aseptic loosening occurs mostly at the tibia component and might be caused by
suboptimal fixation of the prosthesis. Knee prostheses fixated with bone cement
(Polymethylmethacrylaat = PMMA) have equally good or even better results
regarding aseptic loosening and clinical outcome than knee prostheses fixated
without bone cement. The key to optimize the interfacial strength is achieving
and maintaining maximal infiltration of cement into the bone to obtain large
inter-digitation and a large contact area. To improve the cement penetration a
compression device was designed. This device prevents cement leakage and
improves the cement penetration and distribution into the proximal tibia in a
cadaver model.
It is hypothesized that cementation in the proximal tibia after a TKA with the
new cementing compression device is better compared to the best cementing
technique at the moment (finger packing) regarding cement distribution and
cement penetration in vivo.
Study objective
The primary objective is to compare cementation during TKA with a new cementing
device to finger packing (the current best cementing technique) regarding
cement distribution and cement penetration of the proximal tibia.
The secondary objective is to compare the operation time for TKA with and
without this new cementing device.
Study design
We will perform a prospective randomized controlled trial at the Reinier de
Graaf Hospital, Delft, The Netherlands. Patients will be recruited from the
outpatient clinic of the orthopaedic department and evaluated preoperatively,
operatively, 6 weeks and 3 months after surgery.
Intervention
use of the cement compression device during cementation of a total knee
arthroplasty
Study burden and risks
Subjects participating in this stuy have the same risks and benefits when not
participating in this study. We will compare a well recommended technique
(finger packing) with a new technique using a device that is already tested in
a cadaver study. The benefit should be that the penetration and distribution of
the cement in the group using the cementing compression device is more uniform
and predictable. To evaluate the cement distirbution and penetration, a CT scan
of the knee is necessary, 3 months after surgery. This CT scan is extra
compared to regular care.
Toneellaan 2
Zoetermeer 2725 NA
NL
Toneellaan 2
Zoetermeer 2725 NA
NL
Listed location countries
Age
Inclusion criteria
- Non-inflammatory degenerative joint disease (NIDJD), e.g. osteoarthritis,
avascular necrosis
- Traumatic arthritis
- The need for a tibia component size 4, 5, or 6 (NexGen Legacy, Zimmerbiomet)
during surgery
Patients must additionally meet all of the following criteria:
- Age > 18 years
- Patient is willing to participate
- Patient is able to speak and write Dutch
- Patient qualifies for TKP based on medical history and physical examination
- Patient is able and willing to provide written informed consent
Exclusion criteria
- Rheumatoid arthritis or other forms of inflammatory disease
- Uncooperative patient or patient with neurologic disorders who are incapable
of following directions
- Insufficient bone stock to provide adequate support and/or fixation to the
prosthesis
- Metabolic disorders which may impair bone formation
- Osteomalacia
- Charcot's disease
- Previous knee surgery except arthroscopy
Design
Recruitment
Medical products/devices used
metc-ldd@lumc.nl
metc-ldd@lumc.nl
metc-ldd@lumc.nl
metc-ldd@lumc.nl
metc-ldd@lumc.nl
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL70830.098.19 |